Olea Sensor Networks, a leader in intelligent sensors and analytic software for sensor network-based systems, is offering the OSN Digital Health Platform based on Olea’s next-gen version of OleaSense, a technology system for contactless and remote vital sign monitoring.
Olea is offering a digital health development platform for IoT product development and advanced research, featuring advanced data acquisition systems with multi-sensor development platform capabilities. This sophisticated suite of software and hardware building blocks provide fast time-to-market with simpler, more time efficient and more cost-effective method for designing, developing and deploying digital health IoT devices and solutions.
The OleaSense™ advanced software development platforms process real-time data using Olea’s AI signal processing and peak detection algorithms, extracting vital sign statistics such as cardiac, respiration and heart-rate variability or alternatively the presence or absence of life. These IoT platforms offer a suite of components featuring:
Remote data collection from connected devices
Independent and secure connectivity between devices
Device/sensor analytics
Integration with 3rd party systems
Using Olea’s intelligent sensor analytics, the collected data may be transmitted to the cloud for access by professional medical personnel for interpretation and diagnosis. No external wires and no contact with the body is required. The Olea monitoring device weighs about 1 ounce and is about the size of a business card. It may be slipped into a shirt pocket or worn on a lanyard, or embedded in a chair or mattress. It has been clinically tested and provides medical grade accuracy of resting vital signs. It also features the ability to develop an additional feature which provides an individual’s HeartSignature™, which can identify the patient based upon their unique vital sign patterns.
The OSN Digital Health Platform™ is part of Olea’s impressive portfolio of IoT intellectual property and was specifically developed as a vertically integrated solution in such a way that allows an innovative manufacturer to mitigate development cost, increase manufacturing efficiency and accelerate time to market.
“As part of Olea’s intellectual property portfolio offered for licensing to Healthcare companies and manufacturers, the OSN Digital Health Platform™ technology, provides a mutual business advantage,” explained Frank Morese CEO/CTO of Olea, “which helps them to continue to compete globally and allows them to accelerate their innovations. From start-up to large corporations, companies can benefit from development times being reduced from a typical 36 months to only about 6 months, thanks to our manufacturing-ready approach to design.”
Olea offers its IP under a wide variety of licensing models. For each innovation, a customer is able to select the type of licensing that fits their current business plan.
Source: Company Press Release
